Therapy News and Research

RSS

Experimental drug may slow the progression of atherosclerosis

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

8 Jun 2023

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

Patients suffering from the "most horrible" rare brain tumor are falling through the cracks of mental health provision, University of Essex researchers have found.

8 Jun 2023

UC research examines role of a metabolite in the development of abdominal aortic aneurysm

Each year, about 200,000 people in the United States are diagnosed with a bulge in the lower part of the aorta, the main artery in the body, called an abdominal aortic aneurysm (AAA).

8 Jun 2023

“List diving” contributes to disparities in organ transplantation

A kidney from a deceased donor is supposed to be allocated to the top-ranked patient on a transplant center's waiting list, identified using an objective algorithm to rank patients based on patient age, waiting time, and other factors.

8 Jun 2023

New scientific statement details treatment strategies for pediatric cardiomyopathy

Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Jun 2023

Massage therapists ease the pain of hospice patients — but aren’t easy to find

Ilyse Streim views massage for people in hospice care as “whispering to the body through touch.”

8 Jun 2023

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Researchers performed an observational study to determine the prevalence of germline genetic testing among all patients aged 20 years or older diagnosed with cancer between January 1, 2013, and March 31, 2019, in two United States, California and Georgia.

8 Jun 2023

New school-based group counseling programs can significantly reduce PTSD among girls

The University of Chicago Education Lab today released a new study that found school-based group counseling programs can significantly reduce PTSD, anxiety, and depression among Black and Latina girls.

8 Jun 2023

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

A new research paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."

8 Jun 2023

Study analyzes the prevalence of osteoporosis in postmenopausal women

Osteoporosis is a degenerative, debilitating bone disease that is increasingly prevalent in postmenopausal women.

8 Jun 2023

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

Speech and voice disorders are common in individuals with Parkinson's disease. New research published in the International Journal of Language & Communication Disorders found that a tele-rehabilitation program that combines conventional speech therapy and singing may help improve patients' voice problems.

7 Jun 2023

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery.

7 Jun 2023

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital.

7 Jun 2023

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic lymphocytic leukemia (CLL) whether or not their cancer harbored high-risk genetic features typically associated with poor outcomes, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

7 Jun 2023

Study: One in three people with Type 2 diabetes in Austria suddenly stop treatment

A research team led by the Complexity Science Hub Vienna and the Medical University of Vienna has analyzed the actual prevalence of Type 2 diabetes in Austria for the first time as part of a study.

7 Jun 2023

UVA scientists discover a key determinant of multiple sclerosis risk

University of Virginia School of Medicine scientists have discovered a key determinant of our risk for multiple sclerosis (MS), advancing efforts to prevent and better treat the disease.

7 Jun 2023

The HEART Clinic keeps rehab within the reach for stroke, Parkinson’s patients

The first time Craig Hawkins arrived at the free physical therapy clinic, the aftereffects of his stroke weighed heavy. He rolled up in a wheelchair with a tracheotomy, and had already exhausted his medical benefits.

7 Jun 2023

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the comfort of their home.

7 Jun 2023

How do antibiotics affect the ecology of the gut microbiome?

Each person's gut microbiome contains a specific community of microorganisms that normally remains stable for years. However, it can be thrown off balance by factors such as dietary changes, infections or medications. Antibiotics in particular have a strong influence on the microbiome. In response, microorganisms employ various resistance mechanisms, with individual bacterial populations evolving through selection of antibiotic-resistant variants. Yet, the extent and mechanisms of these processes and their impact on the ecology of the microbial community are poorly understood.

7 Jun 2023

Elucidating developmentally sensitive mechanisms of cognitive behavioral therapy

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, "Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive Control Help Kids Grow Out of Illness?" on Tuesday, June 13, 2023, at 2:00 pm EST. The presenter will be Kate D. Fitzgerald, M.D., Ruane Professor of Child and Adolescent Psychiatry at Columbia University/New York State Psychiatric Institute.

7 Jun 2023

Therapy News and Research

Experimental drug may slow the progression of atherosclerosis

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

UC research examines role of a metabolite in the development of abdominal aortic aneurysm

“List diving” contributes to disparities in organ transplantation

New scientific statement details treatment strategies for pediatric cardiomyopathy

Massage therapists ease the pain of hospice patients — but aren’t easy to find

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

New school-based group counseling programs can significantly reduce PTSD among girls

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

Study analyzes the prevalence of osteoporosis in postmenopausal women

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Study: One in three people with Type 2 diabetes in Austria suddenly stop treatment

UVA scientists discover a key determinant of multiple sclerosis risk

The HEART Clinic keeps rehab within the reach for stroke, Parkinson’s patients

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

How do antibiotics affect the ecology of the gut microbiome?

Elucidating developmentally sensitive mechanisms of cognitive behavioral therapy

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News